# Suresh Anne, M.D. – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/suresh-anne-md/0e93834a-f706-4113-b82c-e9796d856b90
Source feed: FDA_Inspections

> FDA inspection 1205635 of Suresh Anne, M.D., May 19, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205635
- Company Name: Suresh Anne, M.D.
- Inspection Date: 2023-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1302630 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/suresh-anne-md/702db3e3-c90d-4154-a9af-af832180260c)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)

Company: https://www.keypedia.com/companies/suresh-anne-md/224b7a49-5956-463a-85ec-097c5b1d8fac

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
